Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Procter & Gamble
PG
$338B
| $766K | ﹤0.01% |
4,494
+1,038
| +30% | +$174K |
|
|
GTLS
2002
CALL
DELISTED
Chart Industries
GTLS
| $765K | ﹤0.01% |
5,300
+2,300
| +77% | +$424K |
|
2003
CALL
LGI Homes
LGIH
$1.37B
| $764K | ﹤0.01% |
11,500
+2,400
| +26% | +$194K |
|
2004
PUT
Fluor
FLR
$6.86B
| $763K | ﹤0.01% |
21,300
+15,700
| +280% | +$678K |
|
2005
Marriott International
MAR
$93.3B
| $761K | ﹤0.01% |
3,195
-5,751
| -64% | -$1.56M |
|
2006
Bluerock Homes Trust
BHM
$35.2M
| $760K | ﹤0.01% |
66,873
| – | – |
|
2007
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
| $759K | ﹤0.01% |
+5,196
| New | +$755K |
|
2008
Mondelez International
MDLZ
$80.4B
| $758K | ﹤0.01% |
11,172
-396,714
| -97% | -$24.5M |
|
2009
CALL
Las Vegas Sands
LVS
$30.6B
| $757K | ﹤0.01% |
19,600
-77,000
| -80% | -$3.4M |
|
2010
Element Solutions
ESI
$8.65B
| $755K | ﹤0.01% |
33,411
-437,896
| -93% | -$11.2M |
|
2011
PUT
Zillow
Z
$8.12B
| $754K | ﹤0.01% |
11,000
+4,800
| +77% | +$367K |
|
2012
CALL
Consolidated Edison
ED
$39.6B
| $752K | ﹤0.01% |
6,800
-7,000
| -51% | -$686K |
|
2013
PUT
Coca-Cola
KO
$394B
| $752K | ﹤0.01% |
10,500
-21,300
| -67% | -$1.42M |
|
2014
CALL
FMC
FMC
$1.4B
| $751K | ﹤0.01% |
+17,800
| New | +$791K |
|
2015
CALL
CF Industries
CF
$19.3B
| $750K | ﹤0.01% |
9,600
+7,000
| +269% | +$587K |
|
2016
PUT
BioMarin Pharmaceuticals
BMRN
$12.8B
| $749K | ﹤0.01% |
10,600
-10,200
| -49% | -$686K |
|
2017
CALL
XP
XP
$9.03B
| $748K | ﹤0.01% |
54,400
-45,800
| -46% | -$631K |
|
2018
CALL
American Eagle Outfitters
AEO
$2.8B
| $747K | ﹤0.01% |
64,300
+49,000
| +320% | +$700K |
|
2019
CALL
Duolingo
DUOL
$6.83B
| $745K | ﹤0.01% |
2,400
-5,400
| -69% | -$1.85M |
|
2020
Carlyle Secured Lending
CGBD
$785M
| $745K | ﹤0.01% |
+46,030
| New | +$813K |
|
2021
PUT
DigitalOcean
DOCN
$13.2B
| $745K | ﹤0.01% |
22,300
+15,200
| +214% | +$594K |
|
2022
CALL
Teva Pharmaceuticals
TEVA
$44.4B
| $744K | ﹤0.01% |
48,400
+13,500
| +39% | +$241K |
|
2023
Jack in the Box
JACK
$320M
| $743K | ﹤0.01% |
+27,341
| New | +$1.01M |
|
2024
CALL
Realty Income
O
$59.5B
| $743K | ﹤0.01% |
+12,800
| New | +$709K |
|
2025
Cognex
CGNX
$10.1B
| $742K | ﹤0.01% |
24,891
-62,309
| -71% | -$2.19M |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.